From: Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma
Median ± SD of PRB expression (2^-∆Ct)
PRB status at day 1
Day 1
Day 15
Control group
PRB+
0.014 ± 0.01
0.010 ± 0.02
PRB-
0.007 ± 0.00
0.007 ± 0.001
Treated group
0.011 ± 0.01
0.006 ± 0.002
0.006 ± 0.003